| Active substance |
Olopatadine |
| Also known as |
Opatanol |
| Blood pressure |
No significant impact |
| Chemical name |
11-[(Z)-3-(Dimethylamino)propylidene]-6-11-dihydrodibenz[b,e]oxepin-2-acetic acid |
| Dosage (medical) |
For allergic conjunctivitis - 0.1% ophthalmic solution, one drop in each affected eye twice a day |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces histamine-induced symptoms like itching, redness, and swelling |
| Formula |
C_21H_23NO_3 |
| Half-life |
Approximately 12 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not specifically required for monitoring olopatadine |
| Main action |
Histamine H1 receptor antagonist |
| Side effects |
Mild taste, headache, sore throat, nasal dryness or irritation |
| Storage conditions |
Store at room temperature, away from moisture and light |
| Strength |
5mg |
| Substance class |
Antihistamine |
| Trade name |
Patanol, Pataday |
| Use in sports |
Not typically used in sports |
| Water Retention |
No significant effect |
| Manufacturer |
Sun Pharma Laboratories Ltd. |
| Packing |
10 tabs/blister |
